000 | 01992ngm a2200385 a 4500 | ||
---|---|---|---|
001 | HST1088_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2007 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a1088 _bHenry Stewart Talks |
035 | _a(UkLoHST)268 | ||
035 | _a(UkLU-K)AC000390309 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aSerretti, Alessandro. _4spk |
|
245 | 1 | 0 |
_aGenetic polymorphisms influencing response to lithium _h[electronic resource] / _cAlessandro Serretti. |
260 |
_aLondon : _bHenry Stewart Talks, _c2007. |
||
300 |
_a1 online resource (1 streaming video file (46 min.) : _bcolor, sound). |
||
490 | 1 |
_aPsychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Lithium treatment in the long-term maintenance of mood disorders -- The issue of evaluating lithium response -- Role of genetic factors -- Mechanism of action of lithium candidate genes in lithium response -- Inositol polyphosphate 1- phosphatase (INNP1) -- Gamma-1 isoenzyme of phospholipase C (PLCG1) -- Tryptophan hydroxylase gene (TPH - A218C) -- Serotonin transporter gene (5-HTTLPR) -- Glycogen synthase kinase 3-beta (GSK3B-50 T/C). | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 2 |
_aLithium _xpharmacology. |
|
650 | 2 |
_aLithium _xtherapeutic use. |
|
650 | 2 | _aPharmacogenetics. | |
650 | 2 | _aPolymorphism, Genetic. | |
650 | 2 | _aPsychopharmacology. | |
650 | 2 | _aPsychotropic Drugs. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pPsychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/268/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/35/ _3Series |
999 |
_c77804 _d77804 |